GILD
GILEAD SCIENCES, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$172.31
+2.89%Leverage
- Debt / equity
- 2.01x
- Net debt / equity
- 1.52x
- Debt / assets
- 0.51x
- Debt / EBITDA
- 31.87x
- Net debt / EBITDA
- 24.05x
Liquidity & coverage
- Current ratio
- 1.38x
- Quick ratio
- 1.22x
- Cash ratio
- 0.54x
- Interest coverage
- -1.34x
- EBITDA / interest
- 0.81x
- Working capital
- $4.6B
Cash & dividend
- FCF / debt
- 0.54x
- Cash flow / debt
- 0.55x
- Dividend per share
- $2.46
- Dividend yield
- 1.4%
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026